Asthma diagnosis and treatmentPrevention of asthma during the first 5 years of life: A randomized controlled trial
Section snippets
Methods
The study design has been described in detail previously,13 and only key features are presented here. The study was a randomized, parallel-group controlled trial using a factorial design that separately tested 2 interventions.
The study was approved by the Human Research Ethics Committees of the University of Sydney, Children's Hospital Westmead, and Western and South Western Sydney Area Health Services.
Results
As previously reported,21 7171 women were screened, of whom 2095 (29%) were eligible for the study, and 616 (29% of those eligible) were enrolled as participants. A survey of 200 eligible nonparticipants revealed that, compared with participants, a lower proportion of parents were tertiary-educated but the parents did not differ in age or proportion who were Australian-born, in full time employment, or primigravida.21
At age 5 years, outcome data were available for 516 (84%) of the 616
Discussion
We have shown that the implementation of feasible strategies directed at reducing exposure to HDM allergens and decreasing the ratio of ω-6 to ω-3 long-chain polyunsaturated fatty acids in the diet during the first 5 years of life does not reduce the prevalence of asthma, other wheezing illness, cough, rhinitis, eczema, or atopic sensitisation at age 5 years in children with a family history of asthma and wheezing. These negative results were obtained despite a 61% reduction in the
Conclusion
The institution of HDM avoidance measures and dietary fatty acid modification, as implemented in this trial, in infancy and early childhood to prevent the onset of asthma and allergic disease in children at increased risk of asthma cannot be recommended. Indeed, the former may be contraindicated because of an increased risk of eczema. The positive findings from some other intervention trials and the observed temporal and geographic variation in the prevalence of asthma support the view that,
References (35)
- et al.
Dust mite allergens and asthma: a worldwide problem
J Allergy Clin Immunol
(1989) - et al.
The Childhood Asthma Prevention Study (CAPS): design and research protocol of a large randomised trial of the primary prevention of asthma
Control Clin Trials
(2001) - et al.
Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the childhood asthma prevention study (CAPS)
J Allergy Clin Immunol
(2003) - et al.
Three year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study (CAPS)
J Allergy Clin Immunol
(2004) - et al.
Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood
J Allergy Clin Immunol
(1999) - et al.
The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age
J Allergy Clin Immunol
(2005) - et al.
Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial
J Allergy Clin Immunol
(2003) - et al.
Indoor allergen exposure is a risk factor for sensitization during the first three years of life
J Allergy Clin Immunol
(1997) - et al.
Manchester Asthma and Allergy Study: low allergen environment can be achieved and maintained during pregnancy and early life
J Allergy Clin Immunol
(2000) - et al.
Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study
J Allergy Clin Immunol
(2001)
Has the prevalence of asthma increased in children? evidence from the national study of health and growth 1973-86
BMJ
Changing prevalence of asthma in Australian children
BMJ
Asthma prevalence in Tokelauan children in two environments
Clin Allergy
Prevalence of asthma and atopy in two areas of West and East Germany
Am J Respir Crit Care Med
Factors in childhood as predictors of asthma in adult life
BMJ
Sensitivity to common allergens: relation to respiratory symptoms and bronchial hyper-responsiveness in children from three different climatic areas of Australia
Clin Exp Allergy
Mite asthma and residency: a case-control study on the impact of exposure to house-dust mites in dwellings
Am Rev Respir Dis
Cited by (0)
Supported by National Health and Medical Research Council of Australia, Cooperative Research Centre for Asthma, New South Wales Department of Health, Children's Hospital Westmead. Dr Almqvist was funded by the Swedish Heart Lung Foundation and Swedish Society of Medicine. Contributions of goods and services were made by Allergopharma Joachim Ganzer KG Germany, John Sands Australia, Hasbro, Toll Refrigerated, AstraZeneca Australia, and Nu-Mega Ingredients Pty Ltd. Goods were provided at reduced cost by Auspharm, Allersearch, and Goodman Fielder Foods.
Disclosure of potential conflict of interest: C. M. Mellis has consultant arrangements with Merck Sharp & Dohme, Altana Pharma. The rest of the authors have declared that they have no conflict of interest.